Dr Martens Plc Stock Working Capital
| DOCMF Stock | USD 0.70 0.07 9.09% |
Dr Martens plc fundamentals help investors to digest information that contributes to Dr Martens' financial success or failures. It also enables traders to predict the movement of DOCMF Pink Sheet. The fundamental analysis module provides a way to measure Dr Martens' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dr Martens pink sheet.
DOCMF |
Dr Martens plc Company Working Capital Analysis
Dr Martens' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
According to the company's disclosures, Dr Martens plc has a Working Capital of 0.0. This is 100.0% lower than that of the Consumer Cyclical sector and 100.0% lower than that of the Footwear & Accessories industry. The working capital for all United States stocks is 100.0% higher than that of the company.
DOCMF Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Martens' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Dr Martens could also be used in its relative valuation, which is a method of valuing Dr Martens by comparing valuation metrics of similar companies.Dr Martens is currently under evaluation in working capital category among its peers.
DOCMF Fundamentals
| Return On Equity | 0.64 | |||
| Return On Asset | 0.16 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 2.75 B | |||
| Shares Outstanding | 1 B | |||
| Shares Owned By Insiders | 3.85 % | |||
| Shares Owned By Institutions | 69.40 % | |||
| Price To Earning | 33.56 X | |||
| Price To Book | 5.71 X | |||
| Price To Sales | 2.43 X | |||
| Revenue | 908.3 M | |||
| Gross Profit | 578.8 M | |||
| EBITDA | 265 M | |||
| Net Income | 181.2 M | |||
| Cash And Equivalents | 228 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 280.9 M | |||
| Debt To Equity | 1.20 % | |||
| Current Ratio | 2.86 X | |||
| Book Value Per Share | 0.35 X | |||
| Cash Flow From Operations | 184.4 M | |||
| Earnings Per Share | 0.21 X | |||
| Price To Earnings To Growth | 0.01 X | |||
| Number Of Employees | 2.23 K | |||
| Beta | 0.0551 | |||
| Market Capitalization | 1.93 B | |||
| Total Asset | 859.1 M | |||
| Z Score | 4.6 | |||
| Annual Yield | 0.04 % | |||
| Net Asset | 859.1 M | |||
| Last Dividend Paid | 0.058 |
About Dr Martens Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dr Martens plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Martens using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Martens plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in DOCMF Pink Sheet
Dr Martens financial ratios help investors to determine whether DOCMF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOCMF with respect to the benefits of owning Dr Martens security.